Published in Mult Scler on January 29, 2007
A randomized trial of 4-aminopyridine in EA2 and related familial episodic ataxias. Neurology (2011) 2.09
Seizures in patients with multiple sclerosis: epidemiology, pathophysiology and management. CNS Drugs (2009) 1.14
Symptomatic therapy in multiple sclerosis: a review for a multimodal approach in clinical practice. Ther Adv Neurol Disord (2011) 0.94
4-aminopyridine toxicity: a case report and review of the literature. J Med Toxicol (2012) 0.93
New approaches in the management of multiple sclerosis. Drug Des Devel Ther (2010) 0.92
Clinically meaningful performance benchmarks in MS: timed 25-foot walk and the real world. Neurology (2013) 0.91
Enhancing neural transmission in multiple sclerosis (4-aminopyridine therapy). Neurotherapeutics (2013) 0.90
Treatment of walking impairment in multiple sclerosis with dalfampridine. Ther Adv Neurol Disord (2011) 0.86
Sustained-released fampridine in multiple sclerosis: effects on gait parameters, arm function, fatigue, and quality of life. J Neurol (2015) 0.80
Effects of 4-Aminopyridine on Cloned hERG Channels Expressed in Mammalian Cells. Arch Drug Inf (2009) 0.78
Targeting ion channels for the treatment of autoimmune neuroinflammation. Ther Adv Neurol Disord (2013) 0.78
Impact of extended-release dalfampridine on walking ability in patients with multiple sclerosis. Neuropsychiatr Dis Treat (2011) 0.78
Oral dalfampridine improves standing balance detected at static posturography in multiple sclerosis. Mult Scler Int (2014) 0.78
Sustained-release fampridine (4-aminopyridine) in multiple sclerosis: efficacy and impact on motor function. Drugs R D (2013) 0.77
Difference in Motor Fatigue between Patients with Stroke and Patients with Multiple Sclerosis: A Pilot Study. Front Neurol (2014) 0.77
Dalfampridine effects on cognition, fatigue, and dexterity. Brain Behav (2016) 0.76
Dalfampridine: review of its efficacy in improving gait in patients with multiple sclerosis. J Cent Nerv Syst Dis (2011) 0.76
Fatigue Management in Multiple Sclerosis. Curr Treat Options Neurol (2016) 0.75
Effect of 4-Aminopyridine on Action Potential Parameters in Isolated Dog Purkinje Fibers. Arch Drug Inf (2010) 0.75
Aminopyridines for the treatment of neurologic disorders. Neurol Clin Pract (2017) 0.75
Extended-release dalfampridine in the management of multiple-sclerosis-related walking impairment. Ther Adv Neurol Disord (2012) 0.75
Dynamic walking features and improved walking performance in multiple sclerosis patients treated with fampridine (4-aminopyridine). BMC Neurol (2015) 0.75
Structure of the replicative form of bacteriphage phi X174. VI. Studies on alkali-denatured double-stranded phi X DNA. J Mol Biol (1968) 11.10
Structure of the replicative form of bacteriophage phi-X-174. VII. Renaturation of denatured double-stranded phi-X DNA. J Mol Biol (1969) 10.46
Complete genome sequence and comparative analysis of the metabolically versatile Pseudomonas putida KT2440. Environ Microbiol (2002) 8.11
Socioeconomic status and breast cancer incidence in California for different race/ethnic groups. Cancer Causes Control (2001) 5.38
A controlled trial comparing continued zidovudine with didanosine in human immunodeficiency virus infection. The NIAID AIDS Clinical Trials Group. N Engl J Med (1992) 4.71
Sedimentation of generalized systems of interacting particles. I. Solution of systems of complete Lamm equations. Biopolymers (1975) 4.49
Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study. Lancet (2007) 4.45
Studies on mustard gas (betabeta'-dichlorodiethyl sulphide) and some related compounds: 5. The fate of injected mustard gas (containing radioactive sulphur) in the animal body. Biochem J (1946) 4.41
Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP panel: spontaneous recovery after spinal cord injury and statistical power needed for therapeutic clinical trials. Spinal Cord (2006) 3.55
A novel ubiquitin-specific protease is dynamically associated with the PML nuclear domain and binds to a herpesvirus regulatory protein. EMBO J (1997) 3.34
Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes. Cancer Res (1994) 3.30
Differential diagnosis of suspected multiple sclerosis: a consensus approach. Mult Scler (2008) 3.28
A point mutation in the neu oncogene mimics ligand induction of receptor aggregation. Nature (1989) 3.27
Hospital peer review and the National Practitioner Data Bank: clinical privileges action reports. JAMA (1999) 3.24
Health of the public. The academic response. Health of the Public Mission Statement Working Group. JAMA (1992) 2.95
Transmembrane ammonium sulfate gradients in liposomes produce efficient and stable entrapment of amphipathic weak bases. Biochim Biophys Acta (1993) 2.92
Practice parameter update: evaluation and management of driving risk in dementia: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology (2010) 2.84
American Academy of Neurology position statement on physician reporting of medical conditions that may affect driving competence. Neurology (2007) 2.79
Social network ties and mortality among the elderly in the Alameda County Study. Am J Epidemiol (1987) 2.69
Predictors of driving safety in early Alzheimer disease. Neurology (2009) 2.61
A new surgical procedure for the treatment of gastroesophageal reflux and hiatal hernia. Surg Gynecol Obstet (1979) 2.57
Cancer-related pain: a pan-European survey of prevalence, treatment, and patient attitudes. Ann Oncol (2009) 2.52
Clinical characteristics of African Americans vs Caucasian Americans with multiple sclerosis. Neurology (2004) 2.50
Comorbidity delays diagnosis and increases disability at diagnosis in MS. Neurology (2008) 2.49
Experimental allergic encephalomyelitis and multiple sclerosis: lesion characterization with magnetization transfer imaging. Radiology (1992) 2.41
Unilateral transplantation of human fetal mesencephalic tissue into the caudate nucleus of patients with Parkinson's disease. N Engl J Med (1992) 2.39
Persistent B19 parvovirus infection in patients infected with human immunodeficiency virus type 1 (HIV-1): a treatable cause of anemia in AIDS. Ann Intern Med (1990) 2.33
A quantitative assay for DNA-DNA hybrids using membrane filters. Biochem Biophys Res Commun (1966) 2.32
The ethics objective structured clinical examination. J Gen Intern Med (1993) 2.32
Guidelines for the conduct of clinical trials for spinal cord injury (SCI) as developed by the ICCP panel: clinical trial outcome measures. Spinal Cord (2006) 2.28
Fungal flora of the normal human small and large intestine. N Engl J Med (1969) 2.25
Loss of suppressor T cells in active multiple sclerosis. Analysis with monoclonal antibodies. N Engl J Med (1980) 2.21
A truncated form of herpes simplex virus type 1 immediate-early protein Vmw110 is expressed in a cell type dependent manner. Virology (1993) 2.21
Sequence and analysis of chromosome 3 of the plant Arabidopsis thaliana. Nature (2000) 2.17
The mechanism of damage to the bone marrow in systemic poisoning with mustard gas. Biochem J (1947) 2.16
Reliability and validity of two self-report measures of impairment and disability for MS. North American Research Consortium on Multiple Sclerosis Outcomes Study Group. Neurology (1999) 2.14
Phase I studies of anti-epidermal growth factor receptor chimeric antibody C225 alone and in combination with cisplatin. J Clin Oncol (2000) 2.13
The SGOT/SGPT ratio--an indicator of alcoholic liver disease. Dig Dis Sci (1979) 2.12
Isolation, characterization, and DNA sequence analysis of an AAC(6')-II gene from Pseudomonas aeruginosa. Antimicrob Agents Chemother (1989) 2.08
Nosocomial infections due to Pseudomonas aeruginosa: review of recent trends. Rev Infect Dis (1984) 2.08
Dose comparison trial of sustained-release fampridine in multiple sclerosis. Neurology (2008) 2.04
Different inherited levels of DNA repair replication in xeroderma pigmentosum cell strains after exposure to ultraviolet irradiation. Mutat Res (1970) 2.03
Prognostic factors for survival and for biochemical cure in medullary thyroid carcinoma: results in 899 patients. The GETC Study Group. Groupe d'étude des tumeurs à calcitonine. Clin Endocrinol (Oxf) (1998) 1.99
Effect of a tumour promoter on myogenesis. Nature (1977) 1.98
Outbreak of a nosocomial infection with a strain of Proteus rettgeri resistant to many antimicrobials. Am J Clin Pathol (1974) 1.95
Endothelial dysfunction in a murine model of mild hyperhomocyst(e)inemia. J Clin Invest (2000) 1.94
Incidence of BK virus and JC virus viruria in human immunodeficiency virus-infected and -uninfected subjects. J Infect Dis (1993) 1.92
Graduates of foreign medical schools: demographic and personal predictors of success on an OSCE-format internship programme entrance examination. Res Med Educ (1988) 1.86
Sequence and analysis of chromosome 1 of the plant Arabidopsis thaliana. Nature (2000) 1.85
Identification of the gene encoding the 65-kilodalton DNA-binding protein of herpes simplex virus type 1. J Virol (1988) 1.81
Phase I trial of a melanoma vaccine with gp100(280-288) peptide and tetanus helper peptide in adjuvant: immunologic and clinical outcomes. Clin Cancer Res (2001) 1.79
Extensive early motor and non-motor behavioral deficits are followed by striatal neuronal loss in knock-in Huntington's disease mice. Neuroscience (2008) 1.76
High frequency of adverse health behaviors in multiple sclerosis. Mult Scler (2008) 1.74
Risk factors for distal symmetric neuropathy in NIDDM. The San Luis Valley Diabetes Study. Diabetes Care (1994) 1.74
Quantification of axonal damage in traumatic brain injury: affinity purification and characterization of cerebrospinal fluid tau proteins. J Neurochem (1999) 1.73
Reliability and construct validity of a structured technical skills assessment form. Am J Surg (1994) 1.72
Does multiple sclerosis-associated disability differ between races? Neurology (2006) 1.71
Identification of a regulatory region that mediates glucose-dependent induction of the Saccharomyces cerevisiae enolase gene ENO2. Mol Cell Biol (1986) 1.69
Visual dysfunction in Parkinson disease without dementia. Neurology (2005) 1.67
Driver landmark and traffic sign identification in early Alzheimer's disease. J Neurol Neurosurg Psychiatry (2005) 1.65
A novel ubiquitin-specific protease is dynamically associated with the PML nuclear domain and binds to a herpesvirus regulatory protein. EMBO J (1997) 1.65
Road safety in drivers with Parkinson disease. Neurology (2009) 1.65
4-Aminopyridine in chronic spinal cord injury: a controlled, double-blind, crossover study in eight patients. J Neurotrauma (1993) 1.65
Sedimentation of generalized systems of interacting particles. II. Active enzyme centrifugation--theory and extensions of its validity range. Biopolymers (1975) 1.64
Shared decision making for in-patients with schizophrenia. Acta Psychiatr Scand (2006) 1.63
Extensive clinical experience: relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism. J Clin Endocrinol Metab (2005) 1.63
Correlation between aminoglycoside resistance profiles and DNA hybridization of clinical isolates. Antimicrob Agents Chemother (1991) 1.62
Airborne endotoxin associated with industrial-scale production of protein products in gram-negative bacteria. Am Ind Hyg Assoc J (1988) 1.61
Antibiotic-resistant isolates of Streptococcus pneumoniae from clinical specimens: a cluster of serotype 19A organisms in Brooklyn, New York. J Infect Dis (1986) 1.60
Paclitaxel-based chemotherapy in carcinoma of the fallopian tube. Gynecol Oncol (2001) 1.59
Resistance to macrolides in Streptococcus pyogenes in France in pediatric patients. Antimicrob Agents Chemother (2000) 1.57
Benefits of Ophdiat, a telemedical network to screen for diabetic retinopathy: a retrospective study in five reference hospital centres. Diabetes Metab (2009) 1.56
Vascular comorbidity is associated with more rapid disability progression in multiple sclerosis. Neurology (2010) 1.56
Laparascopic excision of pelvic kidney with single vaginal ectopic ureter. J Pediatr Surg (1997) 1.56
Clinical characteristics and overall survival in genitourinary sarcomas treated with curative intent: a multicenter study. Eur Urol (2004) 1.56
Percolation in directed scale-free networks. Phys Rev E Stat Nonlin Soft Matter Phys (2002) 1.56
Comorbidity, socioeconomic status and multiple sclerosis. Mult Scler (2008) 1.55
Adsorption of monovalent and divalent cations by phospholipid membranes. The monomer-dimer problem. Biophys J (1981) 1.55
American Academy of Neurology qualifications and guidelines for the physician expert witness. Neurology (2006) 1.54
Structural family versus psychodynamic child therapy for problematic Hispanic boys. J Consult Clin Psychol (1989) 1.53
Penile length is normal in most men seeking penile lengthening procedures. Int J Impot Res (2002) 1.53
Inhaled antibiotics in cystic fibrosis. Lancet (1983) 1.53
Ethics of placebo-controlled clinical trials in multiple sclerosis: a reassessment. Neurology (2008) 1.53
Quinolinic acid in the cerebrospinal fluid of children after traumatic brain injury. Crit Care Med (1999) 1.53
Comparison of the 15q deletions in Prader-Willi and Angelman syndromes: specific regions, extent of deletions, parental origin, and clinical consequences. Am J Med Genet (1990) 1.53
Fibreoptic tracheal intubation after placement of the laryngeal tube. Br J Anaesth (2002) 1.52
Stage- and tissue-specific expression of the neu oncogene in rat development. Proc Natl Acad Sci U S A (1987) 1.52
Immunoablative high-dose cyclophosphamide without stem cell rescue in a patient with pemphigus vulgaris. J Am Acad Dermatol (2000) 1.51
Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP Panel: clinical trial inclusion/exclusion criteria and ethics. Spinal Cord (2006) 1.51
Is the period of rapidly declining adult mortality in the United States coming to an end? Am J Public Health (1983) 1.50
Monoclonal antibody blocking tests for the detection of HSV-1- and HSV-2-specific humoral responses: comparison with western blot assay. J Virol Methods (1995) 1.49